Adolor to License Key Technology from Eli Lilly
Business Review Editor
Abstract
Adolor licenses a series of six patents from Eli Lilly to aid in the development of Alvimopan™, the bowel dysfunction drug.
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.